Literature DB >> 27006100

Induction of cell cycle arrest and apoptosis with downregulation of Hsp90 client proteins and histone modification by 4β-hydroxywithanolide E isolated from Physalis peruviana.

Eun-Jung Park1,2, Mayuramas Sang-Ngern1, Leng Chee Chang1, John M Pezzuto1,2.   

Abstract

SCOPE: Physalis peruviana (Solanaceae) is used for culinary and medicinal purposes. We currently report withanolides, isolated from P. peruviana, inhibit the growth of colon cancer monolayer and spheroid cultures. A detailed mechanistic evaluation was performed with 4β-hydroxywithanolide E (4HWE). METHODS AND
RESULTS: Treatment of HT-29 cells with low concentrations of 4HWE inhibited growth while enhancing levels of p21(Waf1/Cip1) and reducing levels of several cell cycle-related proteins. Apoptosis was induced at higher concentrations. In addition, 4HWE treatment downregulated the levels of Hsp90 client proteins. Nuclear sirtuin 1 (SIRT1) was increased and histone H3 acetylated at lysine 9 was decreased. An additional consequence of SIRT1 elevation in the nucleus may be inhibition of c-Jun activity. The expression of 21 genes was altered, including downregulation of PTGS2, and this correlated with reduced protein levels of cyclooxygenase-2 (COX-2). Overall, efficacious induction of G0/G1 cell cycle arrest at low concentrations, and induction of apoptosis at higher concentrations are interesting 4HWE-mediated phenomena that are accompanied by a complex array of molecular events.
CONCLUSION: Considering the worldwide prevalence of colon cancer, and the unique mode of action mediated by 4HWE, it is reasonable to investigate additional mechanistic details and the potential utility of this compound.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Apoptosis; Cell cycle arrest; Colorectal cancer cell; Cyclooxygenase-2; Sirtuin 1; c-myc

Mesh:

Substances:

Year:  2016        PMID: 27006100     DOI: 10.1002/mnfr.201500977

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  6 in total

1.  Withanolides from Aeroponically Grown Physalis peruviana and Their Selective Cytotoxicity to Prostate Cancer and Renal Carcinoma Cells.

Authors:  Ya-Ming Xu; E M Kithsiri Wijeratne; Ashley L Babyak; Hanna R Marks; Alan D Brooks; Poonam Tewary; Li-Jiang Xuan; Wen-Qiong Wang; Thomas J Sayers; A A Leslie Gunatilaka
Journal:  J Nat Prod       Date:  2017-06-15       Impact factor: 4.050

2.  The Daniel K. Inouye College of Pharmacy Scripts: Poha Berry (Physalis peruviana) with Potential Anti-inflammatory and Cancer Prevention Activities.

Authors:  Leng Chee Chang; Mayuramas Sang-Ngern; John M Pezzuto; Carolyn Ma
Journal:  Hawaii J Med Public Health       Date:  2016-11

Review 3.  Fluctuations of Histone Chemical Modifications in Breast, Prostate, and Colorectal Cancer: An Implication of Phytochemicals as Defenders of Chromatin Equilibrium.

Authors:  Marek Samec; Alena Liskova; Lenka Koklesova; Veronika Mestanova; Maria Franekova; Monika Kassayova; Bianka Bojkova; Sona Uramova; Pavol Zubor; Katarina Janikova; Jan Danko; Samson Mathews Samuel; Dietrich Büsselberg; Peter Kubatka
Journal:  Biomolecules       Date:  2019-12-05

4.  SIRT1 suppresses the migration and invasion of gastric cancer by regulating ARHGAP5 expression.

Authors:  Guoying Dong; Bo Wang; Yifei An; Juan Li; Xin Wang; Jihui Jia; Qing Yang
Journal:  Cell Death Dis       Date:  2018-09-24       Impact factor: 8.469

5.  VALD-3, a Schiff base ligand synthesized from o-vanillin derivatives, induces cell cycle arrest and apoptosis in breast cancer cells by inhibiting the Wnt/β-catenin pathway.

Authors:  Hongling Li; Chunyan Dang; Xiaohui Tai; Li Xue; Yuna Meng; Shuping Ma; Jing Zhang
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

Review 6.  Hidden in Plants-A Review of the Anticancer Potential of the Solanaceae Family in In Vitro and In Vivo Studies.

Authors:  Tomasz Kowalczyk; Anna Merecz-Sadowska; Patricia Rijo; Mattia Mori; Sophia Hatziantoniou; Karol Górski; Janusz Szemraj; Janusz Piekarski; Tomasz Śliwiński; Michał Bijak; Przemysław Sitarek
Journal:  Cancers (Basel)       Date:  2022-03-11       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.